Transfer-pricing treatment of ITeS margins excludes pass-through tax recoveries and separate delayed-receivables interest after working-capital adjust...
Capacity-utilisation adjustments under TNMM can neutralise substantiated COVID-related idle costs where underutilisation materially affects profitabil...
TNMM functional comparability requires excluding rice manufacturers from a pure Basmati rice trader's benchmark and recognising operating export recei...
Working-capital adjustment subsumes delayed-receivable effects in TNMM benchmarking of captive software-development services, avoiding separate notion...
Transfer-pricing comparability requires exclusion of financially illogical super-profit comparables and correction of unsupported annual-report and ma...
Charitable character assessment preserves Section 80G approval despite inclusive spiritual teachings and incidental religious expenditure within the s...
Penalty proceedings for cash-loan acceptance require assessment proceedings and recorded Assessing Officer satisfaction; absent these, the proceedings...
Page of 4828
Press 'Enter' after typing page number.
161 to 180 of 96556 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
The Board found the Company and its promoters/directors guilty of extensive violations spanning FYs 2014-15 to 2019-20, including misstatements in financial statements, improper accounting treatments, and disclosure violations designed to defraud investors. Key violations included incorrect impairment accounting under Ind AS 36, improper capitalization of R&D costs violating AS 26/Ind AS 38, false shareholding pattern disclosures, misleading press releases, inadequate audit coverage of subsidiaries, and non-compliance with GDPR disclosure requirements. The Board imposed market access restrictions on all parties for specified periods, with promoters facing additional directorship bars. The Company must file impact statements with stock exchanges and publish subsidiary financial statements. Monetary penalties were levied against all parties, with promoters receiving higher penalties given their direct benefit from the fraudulent scheme.
The Board found the Company and its promoters/directors guilty of extensive violations spanning FYs 2014-15 to 2019-20, including misstatements in financial statements, improper accounting treatments, and disclosure violations designed to defraud investors. Key violations included incorrect impairment accounting under Ind AS 36, improper capitalization of R&D costs violating AS 26/Ind AS 38, false shareholding pattern disclosures, misleading press releases, inadequate audit coverage of subsidiaries, and non-compliance with GDPR disclosure requirements. The Board imposed market access restrictions on all parties for specified periods, with promoters facing additional directorship bars. The Company must file impact statements with stock exchanges and publish subsidiary financial statements. Monetary penalties were levied against all parties, with promoters receiving higher penalties given their direct benefit from the fraudulent scheme.
Note: It is a system-generated summary and is for quick reference only.